Marker Therapeutics Balance Sheet (2015-2025) | MRKR

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Accumulated Depreciation (Quarter)
Receivables - Accured (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)
64.51M57.22M48.71M42.35M28.64M25.80M18.08M11.78M6.40M18.12M17.50M15.11M11.32M7.80M9.00M19.19M13.69M10.46M17.59M16.07M
Receivables - Net (Quarter)
2.00M2.00M1.70M0.50M0.20M1.90M0.02M9.50M2.30M0.20M
Receivables - Other (Quarter)
1.00M286.00243.00237.000.00M0.63M1.68M2.40M1.00M1.75M0.08M1.03M0.20M0.20M0.30M0.03M2.46M1.67M0.01M1.37M
Receivables (Quarter)
3.68M3.00M3.45M1.53M0.40M2.10M0.32M9.53M4.76M1.67M0.21M
Prepaid Assets (Quarter)
1.96M2.80M2.70M2.48M2.20M2.83M2.67M1.85M2.43M2.09M1.93M0.99M0.92M1.38M1.17M0.00M0.84M
Current Assets (Quarter)
67.47M60.02M51.41M45.98M31.02M29.28M22.42M16.62M10.91M21.96M19.49M17.13M14.09M11.68M10.91M22.02M16.99M14.77M21.73M19.07M
Non-Current Assets
Construction in Progress (Quarter)
2.20M2.23M4.09M
Property, Plant & Equipment (Net) (Quarter)
10.30M10.11M9.85M10.10M10.28M13.74M13.06M12.32M11.70M
Other Non-Current Assets (Quarter)
1.10M0.20M0.59M
Non-Current Assets (Quarter)
20.89M20.45M20.53M22.15M23.94M23.04M18.69M17.80M17.03M
Assets (Quarter)
88.36M80.47M71.94M68.14M54.96M52.32M41.11M34.42M27.94M21.96M19.49M17.13M14.09M11.68M10.91M22.02M16.99M14.77M21.73M19.07M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
3.67M2.04M7.65M11.13M7.35M4.74M5.75M2.52M2.86M2.66M2.30M1.75M1.95M1.68M2.56M1.75M2.09M2.27M1.66M1.30M
Notes Payables (Quarter)
Payables (Quarter)
3.67M2.04M7.65M11.13M7.35M4.74M5.75M2.52M2.86M2.66M2.30M1.75M1.95M1.68M2.56M1.75M2.09M2.27M1.66M1.30M
Accumulated Expenses (Quarter)
0.83M1.10M2.40M2.40M0.75M1.56M2.31M0.75M0.45M0.61M
Other Accumulated Expenses (Quarter)
0.40M0.43M0.36M0.25M0.24M0.30M0.30M0.04M0.29M0.20M0.40M1.33M0.35M0.29M0.90M1.71M0.41M0.66M0.33M
Short term Debt (Quarter)
8.00M5.05M2.50M
Current Leases (Quarter)
0.47M0.56M0.58M0.62M0.68M0.74M0.49M0.58M0.67M
Current Deferred Revenue (Quarter)
1.15M0.20M0.11M1.35M1.40M0.97M
Total Current Liabilities (Quarter)
4.15M5.66M8.23M12.90M8.21M13.47M11.29M7.78M5.20M2.92M2.78M3.07M2.30M1.97M3.46M3.46M2.50M4.28M3.35M2.27M
Non-Current Liabilities
Non-Current Debt (Quarter)
0.10M0.02M0.10M
Liabilities from Discontinued Operations (Quarter)
7.04M0.26M
Operating Leases (Quarter)
11.72M11.57M12.01M11.25M11.72M10.82M7.23M7.04M6.82M
Non-Current Deferred Tax Liability (Quarter)
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)
11.72M11.57M11.43M11.25M11.04M10.82M7.23M7.04M6.82M2.92M
Total Liabilities (Quarter)
15.87M17.23M19.66M24.15M19.25M24.29M18.51M14.82M12.03M2.92M2.78M3.07M2.30M1.97M3.46M3.46M2.50M4.28M3.35M2.27M
Shareholder's Equity
Total Debt (Quarter)
8.10M5.07M2.50M0.10M
Common Equity (Quarter)
72.49M63.24M52.28M43.99M35.71M28.03M22.60M19.60M15.91M19.03M16.71M14.05M11.79M9.70M7.45M18.56M14.49M10.49M18.39M16.80M
Shareholder's Equity (Quarter)
72.49M63.24M52.28M43.99M35.71M28.03M22.60M19.60M15.91M19.03M16.71M14.05M11.79M9.70M7.45M18.56M14.49M10.49M18.39M16.80M
Liabilities and Shareholders Equity (Quarter)
88.36M80.47M71.94M68.14M54.96M52.32M41.11M34.42M27.94M21.96M19.49M17.13M14.09M11.68M10.91M22.02M16.99M14.77M21.73M19.07M
Retained Earnings (Quarter)
-365.02M-375.93M-388.36M-398.12M-408.03M-417.27M-424.19M-428.05M-433.02M-430.50M-433.48M-436.29M-438.68M-440.87M-443.18M-447.02M-451.46M-455.48M-457.48M-459.18M
Treasury Shares (Quarter)
Shares Outstanding (Quarter)
83.01M83.08M83.08M8.31M8.35M8.36M8.36M8.41M8.80M8.80M8.89M8.89M8.91M8.92M8.92M10.71M11.21M11.31M16.70M16.70M